Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of …
Breakthrough invasive fungal infections (IFI s) have emerged as a significant problem in
patients receiving systemic antifungals; however, consensus criteria for defining …
patients receiving systemic antifungals; however, consensus criteria for defining …
Invasive fungal infections in solid organ transplant recipients
Solid organ transplant (SOT) recipients have a significant risk of invasive fungal diseases
(IFD) caused mainly by Candida spp. and Aspergillus spp. Candida spp. is the most frequent …
(IFD) caused mainly by Candida spp. and Aspergillus spp. Candida spp. is the most frequent …
The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and …
The field of cardiothoracic transplantation (CT) has evolved significantly, but infections
remain an important cause of morbidity and mortality, particularly fungal infections (FIs). The …
remain an important cause of morbidity and mortality, particularly fungal infections (FIs). The …
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: a systematic review with qualitative evidence …
M Bassetti, DR Giacobbe, C Grecchi, C Rebuffi… - Journal of Infection, 2020 - Elsevier
Objectives To summarize the available evidence on the diagnostic performance for invasive
aspergillosis (IA) in non-hematological, non-solid organ transplantation critically ill patients …
aspergillosis (IA) in non-hematological, non-solid organ transplantation critically ill patients …
[HTML][HTML] Aspergillosis in solid organ transplantation
Invasive aspergillosis (IA) occurs in 1–15% of the solid organ transplant (SOT) recipients.
Mortality rate in transplant recipients with IA historically has ranged from 65% to 92%(1, 2, 3 …
Mortality rate in transplant recipients with IA historically has ranged from 65% to 92%(1, 2, 3 …
[HTML][HTML] Epidemiology, Clinical Characteristics and Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Infections among Solid Organ Transplant …
RK Shields, CJ Clancy, LM Gillis, EJ Kwak, FP Silveira… - PloS one, 2012 - journals.plos.org
Background Extensively drug-resistant Acinetobacter baumannii (XDR-Ab) has emerged as
a major nosocomial pathogen, but optimal treatment regimens are unknown. Although solid …
a major nosocomial pathogen, but optimal treatment regimens are unknown. Although solid …
Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study
Background Acute rejection, which includes antibody-mediated rejection and acute cellular
rejection, is a risk factor for lung allograft loss. Lung transplant patients often undergo …
rejection, is a risk factor for lung allograft loss. Lung transplant patients often undergo …
Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and …
D Mitsani, MH Nguyen, RK Shields… - Antimicrobial agents …, 2012 - Am Soc Microbiol
Voriconazole prophylaxis is common following lung transplantation, but the value of
therapeutic drug monitoring is unknown. A prospective, observational study of lung …
therapeutic drug monitoring is unknown. A prospective, observational study of lung …
Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care
M Keller, J Sun, C Mutebi, P Shah, D Levine… - The Journal of Heart and …, 2022 - Elsevier
Background As a marker of underlying lung allograft injury, donor-derived cell-free DNA (dd-
cfDNA) may be used to identify episodes of acute allograft injury in lung transplant …
cfDNA) may be used to identify episodes of acute allograft injury in lung transplant …
Safety and effectiveness of isavuconazole treatment for fungal infections in solid organ transplant recipients (ISASOT study)
A Monforte, I Los-Arcos, MT Martín-Gómez… - Microbiology …, 2022 - Am Soc Microbiol
Isavuconazole (ISA) is an alternative treatment for Aspergillus spp. and other fungal
infections, but evidence regarding its use in solid organ transplant recipients (SOTR) is …
infections, but evidence regarding its use in solid organ transplant recipients (SOTR) is …